Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-08-08 00:00:00 ET · period of report 2024-08-07 · accession 0001104659-24-087387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-08 | 2024-08-07 | OBIO | Mack John Prosper | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| D | 2024-08-08 | 2024-08-07 | OBIO | Mack John Prosper | Dir | A - Grant | $0.00 | +40.7K | 40.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2024-08-07 | A | A | 12,864 | $0.00 | 12,864 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on August 7, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 6,003 RSUs vest on June 20, 2025 and (2) the remaining 6,861 RSUs vest in three equal, annual installments beginning on August 7, 2025, subject to the Reporting Person's continuous service through such dates. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-08-07 | A | A | 40,737 | $0.00 | 40,737 | D | $5.83 · — to 2034-08-07 | 40,737 Common Stock | (F2) The stock options shall vest as follows: (1) 19,218 stock options shall vest on June 20, 2025 and (2) the remaining 21,519 stock options shall vest in three equal, annual installments beginning on August 7, 2025, subject to the Reporting Person's continuous service through such date. |